Petrov V I, Onishchenko N V
Institute of Pharmacology, Volgograd State Medical Academy, Ministry of Public Health of the Russian Federation, pl. Pavshikh Bortsov 1, Volgograd, 400131 Russia.
Eksp Klin Farmakol. 2002 Jul-Aug;65(4):66-70.
The paper considers the main trends in development and summarizes the results of experimental and clinical investigations of glutamatergic drugs, including the glutamate synthesis and release inhibitors, NMDA receptor antagonists, AMPA receptor antagonists and positive modulants, and metabotropic glutamate receptors ligands.
本文探讨了其主要发展趋势,并总结了谷氨酸能药物的实验和临床研究结果,包括谷氨酸合成和释放抑制剂、NMDA受体拮抗剂、AMPA受体拮抗剂和正性调节剂,以及代谢型谷氨酸受体配体。